SynthesisClinics (Sao Paulo, Brazil)2022

Inhibition of Toll-like Receptor-4 expression for amelioration of myocardial injury in diabetes: A meta-analysis.

Jinxin Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.